| COVID-19 and healthcare impacts | Lifetime | 91 | GB 20 | 98.00 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | Lifetime | 152 | GB 25 | 99.32 |
| Respiratory Support and Mechanisms | Lifetime | 368 | GB 36 | 98.96 |
| Long-Term Effects of COVID-19 | Lifetime | 300 | GB 38 | 97.46 |
| COVID-19 Clinical Research Studies | Lifetime | 726 | GB 73 | 97.44 |
| Asthma and respiratory diseases | Lifetime | 585 | GB 80 | 98.65 |
| Chronic Disease Management Strategies | Lifetime | 298 | GB 57 | 97.87 |
| Nursing Diagnosis and Documentation | Lifetime | 67 | GB 8 | 97.20 |
| Pediatric health and respiratory diseases | Lifetime | 523 | GB 67 | 96.75 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 835 | GB 55 | 96.31 |
| Emergency and Acute Care Studies | Lifetime | 873 | GB 69 | 96.03 |
| Respiratory and Cough-Related Research | Lifetime | 970 | GB 118 | 95.09 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 398 | GB 80 | 92.74 |
| Delphi Technique in Research | Lifetime | 872 | GB 223 | 86.44 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 1 | GB 1 | 99.83 |
| COVID-19 and healthcare impacts | 2021-2025 | 19 | GB 7 | 99.17 |
| Chronic Disease Management Strategies | 2021-2025 | 10 | GB 5 | 99.28 |
| Long-Term Effects of COVID-19 | 2021-2025 | 107 | GB 26 | 98.63 |
| Respiratory Support and Mechanisms | 2021-2025 | 65 | GB 9 | 99.04 |
| Health Promotion and Cardiovascular Prevention | 2021-2025 | 5 | GB 1 | 97.42 |
| COVID-19 Clinical Research Studies | 2021-2025 | 308 | GB 39 | 98.51 |
| Asthma and respiratory diseases | 2021-2025 | 130 | GB 26 | 98.76 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 160 | GB 16 | 96.98 |
| Pediatric health and respiratory diseases | 2021-2025 | 72 | GB 15 | 94.81 |
| Heart Failure Treatment and Management | 2021-2025 | 385 | GB 34 | 95.33 |
| Climate Change and Health Impacts | 2021-2025 | 471 | GB 29 | 92.96 |
| Respiratory viral infections research | 2021-2025 | 600 | GB 34 | 91.54 |
| Nursing Diagnosis and Documentation | 2021-2025 | 109 | GB 3 | 85.47 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 309 | GB 27 | 86.08 |
| Emergency and Acute Care Studies | 2021-2025 | 941 | GB 84 | 85.29 |
| Respiratory and Cough-Related Research | 2021-2025 | 419 | GB 60 | 87.08 |
| Delphi Technique in Research | 2021-2025 | 277 | GB 68 | 82.96 |
| Pulmonary Hypertension Research and Treatments | 2021-2025 | 862 | GB 51 | 85.93 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 633 | GB 61 | 80.50 |
| Healthcare cost, quality, practices | 2021-2025 | 652 | GB 89 | 75.30 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 819 | GB 40 | 75.80 |
| Medication Adherence and Compliance | 2021-2025 | 748 | GB 40 | 72.60 |
| Adrenal Hormones and Disorders | 2021-2025 | 748 | GB 63 | 68.60 |
